{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_198578.4:c.6058A>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "A",
            "alt": "C",
            "position": "6058"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Radiometric Kinase Activity Assay",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "LRRKtide",
        "Description": "Kinase reactions were performed in duplicate at room temperature in Kinase Buffer S (50 mM Tris-HCl, pH 8.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35) with 2 mM DTT, 400 µM LRRKtide, variable amounts of cold ATP, and 0.5 µCi y32P ATP at a final volume of 30 µL."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The ATP Km,app value for G2019S (169 µM) to be approximately 3-fold higher than wild-type LRRK2 (51 µM), whereas the specific activity for G2019S was approximately 3-fold higher."
        },
        {
          "Variant": "NM_198578.4:c.6058A>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "The ATP Km for I2020T was found to be 7.5 ± 0.4 µM, which is 7-fold lower than that for wild-type LRRK2. The Vmax for 12020T was found to be 44 nmol/(min mg), which is 3-fold lower than that for wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Kinase reactions were performed in duplicate"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "TR-FRET Kinase Activity Assay",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "Fluorescein-ERM (LRRKtide)",
        "Description": "Kinase reactions were performed in 10 µL volumes in black, low-volume 384-well plates (Corning #3676), with 400 nM Fluorescein-ERM (LRRKtide) substrate and 1% DMSO (residual from compound dilutions), in Kinase Buffer S supplemented with 2 mM DTT."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "At ATP Km,app, IC50 values for sunitinb were similar for all LRRK2 variants: 71, 74, and 75 µM for wild-type, G2019S, and I2020T, respectively. However, with ATP at 1 mM wild-type LRRK2 had an IC50 of 370 nM whereas I2020T was incompletely inhibited and had an IC50 value of at least 5 µM. G2019S was modestly more sensitive to inhibition than wild-type LRRK2 with an IC50 value of 230 nM."
        },
        {
          "Variant": "NM_198578.4:c.6058A>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "At ATP Km,app, IC50 values for sunitinb were similar for all LRRK2 variants: 71, 74, and 75 µM for wild-type, G2019S, and I2020T, respectively. However, with ATP at 1 mM wild-type LRRK2 had an IC50 of 370 nM whereas I2020T was incompletely inhibited and had an IC50 value of at least 5 µM. G2019S was modestly more sensitive to inhibition than wild-type LRRK2 with an IC50 value of 230 nM."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "All assays were performed using either three or four replicates for each data point represented."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "TR-FRET Binding Assay",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "Kinase Tracer 236",
        "Description": "Binding assays [14] were performed in 384-well low volume plates (Corning #3676) at room temperature. All binding assays and reagents dilutions were performed in Kinase Buffer S with 2 mM DTT. Final reactions conditions were 10 nM Kinase Tracer 236, 5 nM kinase, 2 nM Eu-anti-GST antibody, variable amounts of test compound (ATP or inhibitor), and 1% residual DMSO (for inhibitors)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ATP affinities were compared among the LRRK2 variants with the TR-FRET competitive binding assay. The affinities were 39 ± 1, 4.5 ± 1, and 75 ± 1 µM for wild-type, I2020T, and G2019S, respectively. Thus, consistent with the Km determinations, I2020T has an approximately 9-fold higher affinity for ATP, whereas the ATP affinity of G2019S is about 2-fold lower than wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.6058A>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ATP affinities were compared among the LRRK2 variants with the TR-FRET competitive binding assay. The affinities were 39 ± 1, 4.5 ± 1, and 75 ± 1 µM for wild-type, I2020T, and G2019S, respectively. Thus, consistent with the Km determinations, I2020T has an approximately 9-fold higher affinity for ATP, whereas the ATP affinity of G2019S is about 2-fold lower than wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}